Nationwide Fund Advisors Novartis Ag Transaction History

Nationwide Fund Advisors

3 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2017 Feb 01, 2018	SELL	$72.33 - $77.64 $13.8 Million - $14.8 Million	-190,230 Closed	0 $0
Q3 2017 Oct 23, 2017	SELL	$74.14 - $77.27 $478,573 - $498,777	-6,455 Reduced 3.28%	190,230 $16.3 Million
Q2 2017 Aug 10, 2017	BUY	N/A	196,685	196,685 $16.4 Million

1,435

133M

1.12M

1.83M

Ticker NVS
Exchange OTC
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 2,151,000,064
Market Cap $224B
Description
Novartis AG researches, develops, manufactures, and markets healthcare products worldwide. The company operates through two segments, Innovative Medicines and Sandoz. The Innovative Medicines segment offers prescription medicines for patients and healthcare providers. It also provides ophthalmology, neuroscience, immunology, hepatology, dermatol...

Get notified when there are updates to the investment portfolio of Nationwide Fund Advisors, based on Form 13F filings with the SEC.

Stay updated on Nationwide Fund Advisors with notifications on news.